-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Theriva Biologics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- Theriva Biologics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $161K, a 58.5% decline year-over-year.
- Theriva Biologics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $867K, a 40.2% decline year-over-year.
- Theriva Biologics, Inc. annual Nonoperating Income (Expense) for 2023 was $1.44M, a 206% increase from 2022.
- Theriva Biologics, Inc. annual Nonoperating Income (Expense) for 2022 was $471K, a 7750% increase from 2021.
- Theriva Biologics, Inc. annual Nonoperating Income (Expense) for 2021 was $6K, a 86.4% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)